| CEO: | Sean M. Smith |
| CFO: | Alexander John Abrey |
| Non-Executive Chairman: | Lykele van der Broek |
| Non-Executive Dir: | Derek McAllan, Robin James Scott Cridland |
| Address: | 67C Innovation Drive, Milton Park, Abingdon, Oxfordshire, England, United Kingdom, OX14 4RQ |
| Website: | http://www.edenresearch.com/ |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB0001646941 |
| Currency | UK Pounds |
| Share Price | 4.45p |
| Change Today | -0.050p |
| % Change | -1.11 % |
| 52 Week High | 4.80 |
| 52 Week Low | 2.10 |
| Volume | 518,281 |
| Shares Issued | 533.35m |
| Market Cap | £23.73m |
| Beta | 0.44 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 11:01 | 614 @ 4.40p |
| 09:52 | 224,966 @ 4.45p |
| 10:48 | 30,000 @ 4.45p |
| 10:08 | 75,000 @ 4.41p |
| 09:58 | 313 @ 4.49p |
| CFO | Alexander John Abrey |
| CEO | Sean M. Smith |
You are here: research